title: [Probable hepatoxicity from epigallocatecol gallate used for phytotherapy].
authors.forename: Laurent
authors.initials: L
authors.lastname: Peyrin-Biroulet
authors.forename: Nadine
authors.initials: N
authors.lastname: Petitpain
authors.forename: Philippe
authors.initials: P
authors.lastname: Kalt
authors.forename: David
authors.initials: D
authors.lastname: Ancel
authors.forename: Fabien
authors.initials: F
authors.lastname: Petit-Laurent
authors.forename: Philippe
authors.initials: P
authors.lastname: Trechot
authors.forename: Hélène
authors.initials: H
authors.lastname: Barraud
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Bronowicki
mesh_terms: D019440:Anti-Obesity Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005260:Female; D005707:Gallic Acid / Q000009:adverse effects* / Q000031:analogs & derivatives; D006801:Humans; D008875:Middle Aged; D008517:Phytotherapy / Q000009:adverse effects*
chemical_list: D019440:Anti-Obesity Agents; C491764:epigallocatecol gallate; D005707:Gallic Acid